北京市天元律师事务所 本所及经办律师同意将本法律意见作为本次股东大会公告的法定文件，随同其他 公告文件一并提交深圳证券交易所（以下简称"深交所"）予以审核公告，并依法对出 具的法律意见承担责任。 关于创业慧康科技股份有限公司 2025 年第一次临时股东大会的法律意见 京天股字（2025）第 641 号 致：创业慧康科技股份有限公司 创业慧康科技股份有限公司（以下简称"公司"）2025 年第一次临时股东大会 （以下简称"本次股东大会"）采取现场投票与网络投票相结合的方式召开，现场会 议于 2025 年 10 月 15 日（星期三）14:30 在杭州市滨江区浦沿街道坚塔街 708 号创 业慧康大厦三楼会议室召开。北京市天元律师事务所（以下简称"本所"）接受公司 聘任，指派本所律师参加本次股东大会现场会议，并根据《中华人民共和国公司法》 《中华人民共和国证券法》（以下简称《证券法》）、《上市公司股东会规则》（以下 简称《股东会规则》）以及《创业慧康科技股份有限公司章程》（以下简称《公司章 程》）等有关规定，就本次股东大会的召集、召开程序、出席现场会议人员的资格、 召集人资格、会议表决程序及表决结果等事项出具本法律意 ...

为贯彻落实《中华人民共和国公司法》，进一步提升上市公司规范运作水平， 公司根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司章程 指引（2025 年修订）》《深圳证券交易所创业板股票上市规则（2025 年修订）》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作 （2025 年修订）》等相关法律法规及规范性文件的规定，结合公司经营发展需 要，根据新修订的《公司法》和《公司章程》的有关规定，公司董事会决定： （一）选举董事长张吕峥为代表公司执行公司事务的董事，并担任公司的 法定代表人。任期自本次董事会审议通过之日起至本届董事会任期届满之日止。 本次选举后，公司法定代表人未发生变更。 （二）确认公司第八届董事会审计委员会仍由谭青女士（独立董事）、蔡家 楣先生（独立董事）、应晶先生三位董事组成，审计委员会成员中独立董事占多 数，并由会计专业人士谭青女士担任召集人。任期自本次董事会审议通过之日 第八届董事会第二十次会议决议的公告 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 创业慧康科技股份有限公司（以下简称"公司"或"本公司"）第八 ...

本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会无新增、变更、否决提案的情况； 2、本次股东大会不涉及变更前次股东大会的决议； 3、本次股东大会以现场投票和网络投票相结合的方式召开； 4、为尊重中小投资者利益，提高中小投资者对本次股东大会决议事项的参 与度，本次股东大会对审议影响中小投资者利益的重大事项进行单独计票。中小 投资者是指除上市公司董事、监事、高级管理人员以及单独或者合计持有公司 5%以上股份的股东以外的其他股东。 一、会议召开和出席情况 证券代码：300451 证券简称：创业慧康 公告编号：2025-057 创业慧康科技股份有限公司 2025年第一次临时股东大会决议公告 （一）会议召开情况 1、召开时间： （1）现场会议日期和时间：2025 年 10 月 15 日（星期三）下午 14:30 （2）网络投票日期和时间：2025 年 10 月 15 日。其中，通过深圳证券交易 所交易系统进行网络投票的具体时间为：2025年10月15日9:15-9:25、9:30-11:30， 13:00-15:00。通过深圳证券交易所互联网投票 ...

Summary of Key Points Core Viewpoint - Several companies are experiencing significant shareholder reductions, with multiple stakeholders planning to decrease their holdings by various percentages, indicating potential shifts in investor confidence and market dynamics [1]. Shareholder Reductions - Watson Pharmaceutical's controlling shareholder plans to reduce holdings by up to 3% [1] - Tianli Lithium Energy's New Materials Fund intends to reduce holdings by up to 3% [1] - Guangkang Biochemical's shareholder Ruihong Kaiyin No.1 plans to reduce holdings by up to 2.6757% [1] - Huayi Technology's shareholder Huang Daqing aims to reduce holdings by no more than 3% [1] - Magu Technology's shareholder Xu Longxiang plans to reduce holdings by up to 0.86% [1] - Saiwu Technology's shareholders Suzhou Suyu and Suzhou Saiying plan to collectively reduce holdings by 1.32% [1] - New Xunda's Minmetals International Trust has cumulatively reduced holdings by 1% [1] - Yandong Micro's Jingguorui has cumulatively reduced 1% of company shares [1] - Aohua Endoscopy's shareholders Junlian Xinkang and Gao Shen have cumulatively reduced 1.92% of shares [1] - Zhejiang Natural's Tiantai Ruiju Equity Investment Center has completed a 1% reduction in company shares [1] - Chunzong Technology's He Shida has cumulatively reduced 2 million shares [1] - Chiao Sensor's Li Hongqing has reduced 16 million shares through block trading [1] - Chuangye Huikang's Philips has cumulatively reduced 1.0195% of shares [1] Other Notable Events - Ruyi Group is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [1] - Huangting International has terminated plans for significant asset sales and debt restructuring [1]

Core Viewpoint - Philips has reduced its stake in Chuangyue Huikang by selling a total of 15,793,764 shares, representing approximately 1.02% of the company's total share capital [1] Summary by Relevant Sections Shareholding Changes - Philips has executed a reduction of its shareholding in Chuangyue Huikang through centralized bidding and block trading methods [1] - The total shares sold by Philips account for 1.019528% of the company's total share capital, and 1.022630% when excluding shares held in the company's repurchase account [1]

Core Viewpoint - Philips (China) Investment Co., Ltd. plans to reduce its stake in Chuangye Huikang (300451.SZ) by approximately 15.79 million shares, representing 1.019528% of the company's total share capital, decreasing its ownership from 9.999996% to 8.977366% [1] Group 1 - The share reduction will occur between September 25, 2025, and October 10, 2025, through centralized bidding and block trading methods [1] - This equity change will not result in a change of control for the company and will not significantly impact its governance structure or ongoing operations [1]

Core Viewpoint - The company, Chuangye Huikang (300451.SZ), announced that Philips (China) Investment Co., Ltd. will reduce its shareholding in the company from 9.999996% to 8.977366% through centralized bidding and block trading, totaling 15.79 million shares, which will not affect the company's control or governance structure [1] Summary by Relevant Sections - **Shareholding Change** - Philips will reduce its stake in Chuangye Huikang by 15.79 million shares, decreasing its ownership percentage from 9.999996% to 8.977366% [1] - The total shares reduced represent approximately 1.019528% of the company's total share capital [1] - **Impact on Company** - The reduction in shareholding will not lead to a change in control of the company [1] - There will be no significant impact on the company's governance structure or ongoing operations [1]

证券代码：300451 证券简称：创业慧康 公告编号：2025-056 创业慧康科技股份有限公司 | 1.基本情况 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 信息披露义务人 | | | 飞利浦（中国）投资有限公司 | | | | | 住所 | | 上海市静安区灵石路718号A1幢 | | | | | | 权益变动时间 | | 2025年10月10日 飞利浦（中国）投资有限公司基于自身战略安排和需求， | | | | | | 权益变动过程 | | 于2025年9月25日至2025年10月10日通过集中竞价及大宗交易 方式合计减持公司股份15,793,764股，所持公司股份比例从 9.999996%下降至8.977366%（注：总股本按剔除公司回购专 用账户中的股份数量4,698,200股后的股数1,544,426,492股计 算，下同），权益变动触及1%的整数倍。 本次权益变动不会导致公司控制权发生变更，不会对公司 | | | | | | 股票简称 | | 治理结构及持续经营产生重大影响。 创业慧康 300451 | 股票代码 | | ...

Core Viewpoint - The company, Chuangshihui Kang (300451.SZ), focuses on the field of healthcare information technology, emphasizing smart healthcare, regional health, and healthy cities as its core development directions [1] Company Focus - The company is currently not involved in smart government services [1]

Core Viewpoint - The company, Chuangshihui Kang (300451.SZ), remains focused on the field of healthcare information technology, emphasizing smart healthcare, regional health, and healthy cities as its core development directions [1] Company Focus - The company does not currently engage in smart government business [1]